News

Japanese pharmaceutical company Otsuka has moved to deepen its presence in the emerging neuroplastogen space through an agreement to acquire Transcend Therapeutics, bringing with it a promising MDMA-based candidate targeting post-traumatic stress disorder (PTSD) and related psychiatric conditions. The...

Novartis has entered into an agreement to acquire biotech firm Excellergy, a move that will bring a next-generation anti-immunoglobulin e (IgE) programme into its pipeline. Excellergy acquisition is structured at up to $2bn in upfront and milestone payments and...

As a life sciences leader, you are uniquely positioned to bridge the gap between innovation and implementation, but the journey to the patient can appear fragmented within traditional hospital systems. For orthopedics, the private practice model has become a...

Regulatory expectations across the life sciences industries are changing, with more focus on clear and measurable exposure data. Starting from early-stage drug development through to large-scale manufacturing, you are expected to show how chemical, biological and physical agents may...

In today’s healthcare and pharmaceutical environment, patient communication directly influences clinical outcomes, brand perception and long-term product success. As therapies become more complex and patient journeys more fragmented, pharmaceutical companies and healthcare providers must ensure that every interaction delivers...

The aesthetics industry is becoming a more popular career path for people with medical backgrounds. If you would also like to explore those services, you’ll need training to provide them safely. We partnered with The American Association of Aesthetic...

The move toward in-home care is driven by various demands, primarily the desire for comfort and the health care industry’s need for better outcomes. When seniors have professional support at home, it may translate to better treatment adherence and...